High-yield and scalable cell-free assembly of virus-like particles by dilution

Biochemical Engineering Journal

Volumn 67, Issue , 2012, Pages 88-96

  Liew, Mervyn W O ^a   Chuan, Yap P ^a   Middelberg, Anton P J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bioprocess design; Downstream processing; Process integration; Scale up; Self assembly; Virus like particles

Indexed keywords

BIOPROCESS DESIGN; DOWNSTREAM-PROCESSING; PROCESS INTEGRATION; SCALE-UP; VIRUS-LIKE PARTICLES;

ANTIGENS; DIALYSIS; DIALYSIS MEMBRANES; ESCHERICHIA COLI; MANUFACTURE; SELF ASSEMBLY; VACCINES; VIRUSES;

ASSEMBLY;

VACCINE;

ARTICLE; BIOPROCESS; BIOREACTOR; CONCENTRATION (PARAMETERS); DIALYSIS; DILUTION; FEASIBILITY STUDY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN DEPLETION; QUANTITATIVE ANALYSIS; QUANTUM YIELD; STEADY STATE; STREPTOCOCCUS GROUP A; VIRUS LIKE AGENT;

ESCHERICHIA COLI; STREPTOCOCCUS SP. 'GROUP A';

EID: 84862674284     PISSN: 1369703X     EISSN: 1873295X     Source Type: Journal    
DOI: 10.1016/j.bej.2012.05.007     Document Type: Article

References (48)

1. McAleer W.J., Buynak E.B., Maigetter R.Z., Wampler D.E., Miller W.J., Hilleman M.R. Human hepatitis B vaccine from recombinant yeast. Nature 1984, 307:178-180.
2. Villa L.L., Costa R.L.R., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., Wheeler C.M., Koutsky L.A., Malm C., Lehtinen M., Skjeldestad F.E., Olsson S.E., Steinwall M., Brown D.R., Kurman R., Ronnett B.M., Stoler M.H., Ferenczy A., Harper D.M., Tamms G.M., Yu J., Lupinacci L., Railkar R., Taddeo F.J., Jansen K.U., Esser M.T., Sings H.L., Saah A.J. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005, 6:271-278.
3. Paavonen J., Naud P., Salmeron J., Wheeler C.M., Chow S.N., Apter D., Kitchener H., Castellsague X., Teixeira J.C., Skinner S.R., Hedrick J., Jaisamrarn U., Limson G., Garland S., Szarewski A., Romanowski B., Aoki F.Y., Schwarz T.F., Poppe W.A.J., Bosch F.X., Jenkins D., Hardt K., Zahaf T., Descamps D., Struyf F., Lehtinen M., Dubin G., Greenacre M., Group H.P.S. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009, 374:301-314.
4. Grgacic E.V.L., Anderson D.A. Virus-like particles: passport to immune recognition. Methods 2006, 40:60-65.
5. Chackerian B., Lowy D.R., Schiller J.T. Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J. Clin. Invest. 2001, 108:415-423.
6. Slupetzky K., Shafti-Keramat S., Lenz P., Brandt S., Grassauer A., Sara M., Kirnbauer R. Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops. J. Gen. Virol. 2001, 82:2799-2804.
7. Ionescu R.M., Przysiecki C.T., Liang X.P., Garsky V.M., Fan J.A., Wang B., Troutman R., Rippeon Y., Flanagan E., Shiver J., Shi L. Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier. J. Pharm. Sci. 2006, 95:70-79.
8. Middelberg A.P.J., Rivera-Hernandez T., Wibowo N., Lua L.H.L., Fan Y., Magor G., Chang C., Chuan Y.P., Good M.F., Batzloff M.R. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. Vaccine 2011, 29:7154-7162.
9. Pattenden L.K., Middelberg A.P.J., Niebert M., Lipin D.I. Towards the preparative and large-scale precision manufacture of virus-like particles. Trends Biotechnol. 2005, 23:523-529.
10. Jennings G.T., Bachmann M.F. Coming of age of virus-like particle vaccines. Biol. Chem. 2008, 389:521-536.
11. Buckland B.C. The process development challenge for a new vaccine. Nat. Med. 2005, 11:S16-S19.
12. Salunke D.M., Caspar D.L.D., Garcea R.L. Polymorphism in the assembly of polyomavirus capsid protein VP1. Biophys. J. 1989, 56:887-900.
13. Rayment I., Baker T.S., Caspar D.L.D., Murakami W.T. Polyoma-virus capsid structure at 22.5-A resolution. Nature 1982, 295:110-115.
14. Adam Z. To build a virus capsid: an equilibrium model of the self assembly of polyhedral protein complexes. J. Mol. Biol. 1994, 241:59-67.
15. 2+-triggered switch in the thermodynamic attraction between structural protein capsomeres. J. R. Soc. Interface 2010, 7:409-421.
16. Gleiter S., Lilie H. Coupling of antibodies via protein Z on modified polyoma virus-like particles. Protein Sci. 2001, 10:434-444.
17. Ding Y., Chuan Y.P., He L.Z., Middelberg A.P.J. Modeling the competition between aggregation and self-assembly during virus-like particle processing. Biotechnol. Bioeng. 2010, 107:550-560.
18. Hanslip S.J., Zaccai N.R., Middelberg A.P.J., Falconer R.J. Assembly of human papillomavirus type-16 virus-like particles: multifactorial study of assembly and competing aggregation. Biotechnol. Prog. 2006, 22:554-560.
19. Peixoto C., Sousa M.F.Q., Silva A.C., Carrondo M.J.T., Alves P.M. Downstream processing of triple layered rotavirus like particles. J. Biotechnol. 2007, 127:452-461.
20. Leavitt A.D., Roberts T.M., Garcea R.L. Polyoma-virus major capsid protein, VP1 - purification after high-level expression in Escherichia coli. J. Biol. Chem. 1985, 260:2803-2809.
21. Liew M.W.O., Rajendran A., Middelberg A.P.J. Microbial production of virus-like particle vaccine protein at gram-per-litre levels. J. Biotechnol. 2010, 150:224-231.
22. Chuan Y.P., Lua L.H.L., Middelberg A.P.J. High-level expression of soluble viral structural protein in Escherichia coli. J. Biotechnol. 2008, 134:64-71.
23. Lipin D.I., Lua L.H.L., Middelberg A.P.J. Quaternary size distribution of soluble aggregates of glutathione-S-transferase-purified viral protein as determined by asymmetrical flow field flow fractionation and dynamic light scattering. J. Chromatogr. A 2008, 1190:204-214.
24. Chen X.J.S., Casini G., Harrison S.C., Garcea R.L. Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. J. Mol. Biol. 2001, 307:173-182.
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
26. Yuan Y., Shane E., Oliver C.N. Reversed-phase high-performance liquid chromatography of virus-like particles. J. Chromatogr. A 1998, 816:21-28.
27. Chuan Y.P., Fan Y.Y., Lua L., Middelberg A.P.J. Quantitative analysis of virus-like particle size and distribution by field-flow fractionation. Biotechnol. Bioeng. 2008, 99:1425-1433.
28. Lo C.T., Jahn A., Locascio L.E., Vreeland W.N. Controlled self-assembly of monodisperse niosomes by microfluidic hydrodynamic focusing. Langmuir 2010, 26:8559-8566.
29. Brady J.N., Winston V.D., Consigli R.A. Dissociation of polyoma-virus by chelation of calcium-ions found associated with purified virions. J. Virol. 1977, 23:717-724.
30. Salunke D.M., Caspar D.L.D., Garcea R.L. Self-assembly of purified polyomavirus capsid protein VP1. Cell 1986, 46:895-904.
31. Haynes J.I., Chang D.C., Consigli R.A. Mutations in the putative calcium-binding domain of polyomavirus VP1 affect capsid assembly. J. Virol. 1993, 67:2486-2495.
32. Schmidt U., Rudolph R., Bohm G. Mechanism of assembly of recombinant murine polyomavirus-like particles. J. Virol. 2000, 74:1658-1662.
33. Stehle T., Yan Y., Benjamin T.L., Harrison S.C. Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 1994, 369:160-163.
34. Stehle T., Harrison S.C. Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure 1996, 4:183-194.
35. Shi L., Sanyal G., Ni A., Luo Z., Doshna S., Wang B., Graham T.L., Wang N., Volkin D.B. Stabilization of human papillomavirus virus-like particles by non-ionic surfactants. J. Pharm. Sci. 2005, 94:1538-1551.
36. Diehl K.H., Hull R., Morton D., Pfister R., Rabemampianina Y., Smith D., Vidal J.M., van de Vorstenbosch C. A good practice guide to the administration of substances and removal of blood, including routes and volumes. J. Appl. Toxicol. 2001, 21:15-23.
37. Gedvilaite A., Zvirbliene A., Staniulis Z., Sasnauskas K., Kruger D.H., Ulrich R. Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice. Viral Immunol. 2004, 17:51-68.
38. Yin Y., Zhang J., Dong D.Y., Liu S.L., Guo Q., Song X.H., Li G.L., Fu L., Xu J.J., Chen W. Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis. Vaccine 2008, 26:5814-5821.
39. Maranga L.M., Rueda P.R., Antonis A.A., Vela C.V., Langeveld J.L., Casal J.C., Carrondo M.C. Large scale production and downstream processing of a recombinant porcine parvovirus vaccine. Appl. Microbiol. Biotechnol. 2002, 59:45-50.
40. Kim K.J., Chen V., Fane A.G. Some factors determining protein aggregation during ultrafiltration. Biotechnol. Bioeng. 1993, 42:260-265.
41. Scigelova M., Green P.S., Giannakopulos A.E., Rodger A., Crout D.H.G., Derrick P.J. A practical protocol for the reduction of disulfide bonds in proteins prior to analysis by mass spectrometry. Eur. J. Mass Spectrom. 2001, 7:29-34.
42. Nilsson J., Miyazaki N., Xing L., Wu B., Hammar L., Li T.C., Takeda N., Miyamura T., Cheng R.H. Structure and assembly of a T=1 virus-like particle in BK polyomavirus. J. Virol. 2005, 79:5337-5345.
43. Chen P.L., Wang M.L., Ou W.C., Lii C.K., Chen L.S., Chang D.C. Disulfide bonds stabilize JC virus capsid-like structure by protecting calcium ions from chelation. FEBS Lett. 2001, 500:109-113.
44. Ishizu K.I., Watanabe H., Han S.I., Kanesashi S.N., Hoque M., Yajima H., Kataoka K., Handa H. Roles of disulfide linkage and calcium ion-mediated interactions in assembly and disassembly of virus-like particles composed of simian virus 40 VP1 capsid protein. J. Virol. 2001, 75:61-72.
45. 2+-EDTA interactions: calorimetric study. Biophys. Chem. 1999, 79:117-127.
46. Kiefhaber T., Rudolph R., Kohler H.-H., Buchner J. Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Nat. Biotechnol. 1991, 9:825-829.
47. Mach H., Volkin D.B., Troutman R.D., Wang B., Luo Z., Jansen K.U., Shi L. Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs). J. Pharm. Sci. 2006, 95:2195-2206.
48. Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., Ferrin T.E. UCSF chimera - a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.